» Articles » PMID: 10543611

High-capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy

Overview
Journal Hum Gene Ther
Specialties Genetics
Pharmacology
Date 1999 Oct 30
PMID 10543611
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The availability of efficient and nontoxic gene delivery technologies is fundamental to the translation of therapeutic concepts into clinical practice by gene transfer. High-capacity adenoviral (HC-Ad) vectors are characterized by the ability to transduce cells in vitro and in vivo with more than 30 kb of nonviral DNA. This quality allows simultaneous gene transfer of several expression cassettes, large promoters, and some genes in their natural genomic context. Because all viral coding sequences are removed from these vectors, safety is considerably improved compared with previous-generation adenoviral vectors.

Citing Articles

Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties.

Daussy C, Pied N, Wodrich H Viruses. 2021; 13(7).

PMID: 34202573 PMC: 8310329. DOI: 10.3390/v13071221.


Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma.

Li J, Wang W, Wang J, Cao Y, Wang S, Zhao J Front Oncol. 2021; 11:678226.

PMID: 34055646 PMC: 8155537. DOI: 10.3389/fonc.2021.678226.


Gene Therapy in the Anterior Eye Segment.

Amador C, Shah R, Ghiam S, Kramerov A, Ljubimov A Curr Gene Ther. 2021; 22(2):104-131.

PMID: 33902406 PMC: 8531184. DOI: 10.2174/1566523221666210423084233.


Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production.

Rodrigues A, Fernandes P, Laske T, Castro R, Alves P, Genzel Y Int J Mol Sci. 2020; 21(17).

PMID: 32854295 PMC: 7504089. DOI: 10.3390/ijms21176111.


Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice.

Zeng J, Meng X, Zhou P, Yin Z, Xie Q, Zou H Arthritis Res Ther. 2019; 21(1):205.

PMID: 31481114 PMC: 6724270. DOI: 10.1186/s13075-019-1985-9.